129 related articles for article (PubMed ID: 11349621)
1. [Markers for the prognosis of success of coronary interventions: focus on changes in fibrinolysis and hemostasis].
Hoffmeister HM
Herz; 2001 Apr; 26 Suppl 1():19-23. PubMed ID: 11349621
[TBL] [Abstract][Full Text] [Related]
2. Correlation between coronary morphology and molecular markers of fibrinolysis in unstable angina pectoris.
Hoffmeister HM; Jur M; Helber U; Fischer M; Heller W; Seipel L
Atherosclerosis; 1999 May; 144(1):151-7. PubMed ID: 10381288
[TBL] [Abstract][Full Text] [Related]
3. Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction.
Hoffmeister HM; Jur M; Ruf-Lehmann M; Helber U; Heller W; Seipel L
J Am Coll Cardiol; 1998 Mar; 31(3):547-51. PubMed ID: 9502633
[TBL] [Abstract][Full Text] [Related]
4. Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris.
Hoffmeister HM; Jur M; Wendel HP; Heller W; Seipel L
Circulation; 1995 May; 91(10):2520-7. PubMed ID: 7743613
[TBL] [Abstract][Full Text] [Related]
5. The influence of coronary angiography and angioplasty on parameters of hemostasis and fibrinolysis.
Six AJ; Tjon RM; Buys EM; Haas F; Hollander-van Zalk A; Haverkate F
Thromb Haemost; 1990 Aug; 64(1):113-6. PubMed ID: 2148844
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters.
Suzuki S; Matsuo T; Kobayashi H; Matsuo M; Shimamo C; Koide M; Sakamoto S
Thromb Res; 2000 May; 98(4):269-79. PubMed ID: 10822073
[TBL] [Abstract][Full Text] [Related]
7. [Blood coagulation and fibrinolysis in arteriosclerosis].
Hoffmeister HM; Heller W; Seipel L
Z Kardiol; 1999 May; 88(5):315-23. PubMed ID: 10413853
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous interventions alter the hemostatic profile of patients with unstable versus stable angina.
Yazdani S; Simon AD; Kovar L; Wang W; Schwartz A; Rabbani LE
J Am Coll Cardiol; 1997 Nov; 30(5):1284-7. PubMed ID: 9350928
[TBL] [Abstract][Full Text] [Related]
9. Evidence for reduced fibrinolytic activity in unstable angina at rest. Clinical, biochemical, and angiographic correlates.
Zalewski A; Shi Y; Nardone D; Bravette B; Weinstock P; Fischman D; Wilson P; Goldberg S; Levin DC; Bjornsson TD
Circulation; 1991 May; 83(5):1685-91. PubMed ID: 1902406
[TBL] [Abstract][Full Text] [Related]
10. Transmyocardial fibrinolytic activity in patients with unstable angina pectoris.
Daniel WC; Meidell RS; Hillis LD; Lange RA
Coron Artery Dis; 1996 Jan; 7(1):45-9. PubMed ID: 8773432
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.
Aznar J; Estellés A; Tormo G; Sapena P; Tormo V; Blanch S; España F
Br Heart J; 1988 May; 59(5):535-41. PubMed ID: 3132963
[TBL] [Abstract][Full Text] [Related]
12. Changes of hemostasis, endogenous fibrinolysis, platelet activation and endothelins after percutaneous transluminal coronary angioplasty in patients with stable angina.
Borries M; Heins M; Fischer Y; Stiegler H; Peters A; Reinauer H; Schoebel FC; Strauer BE; Leschke M
J Am Coll Cardiol; 1999 Aug; 34(2):486-93. PubMed ID: 10440163
[TBL] [Abstract][Full Text] [Related]
13. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis.
Strauss BH; Lau HK; Bowman KA; Sparkes J; Chisholm RJ; Garvey MB; Fenkell LL; Natarajan MK; Singh I; Teitel JM
Circulation; 1999 Oct; 100(15):1616-22. PubMed ID: 10517732
[TBL] [Abstract][Full Text] [Related]
14. The relationship between hemostatic tests and cardiovascular risk factors in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities (ECAT) Angina Pectoris Group.
Haverkate F; Thompson SG; van de Loo JC
Ann Epidemiol; 1992 Jul; 2(4):521-4. PubMed ID: 1342302
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.
Juhan-Vague I; Thompson SG; Jespersen J
Arterioscler Thromb; 1993 Dec; 13(12):1865-73. PubMed ID: 8241109
[TBL] [Abstract][Full Text] [Related]
16. Hemostatic and fibrinolytic activation is less following cutting balloon angioplasty of the coronary arteries.
Namiki A; Toma H; Nakamura M; Matsuda K; Hara H; Hara H; Asahara T; Soumitsu Y; Kobayashi N; Yamaguchi T
Jpn Heart J; 2004 May; 45(3):409-17. PubMed ID: 15240961
[TBL] [Abstract][Full Text] [Related]
17. [Role of the hemostasis in unstable angina pectoris].
Lisowski P; Małyszko J; Lisowska A; Czech B; Myśliwiec M; Jackowski R; Hirnle T
Pol Merkur Lekarski; 2004 May; 16(95):468-71. PubMed ID: 15518429
[TBL] [Abstract][Full Text] [Related]
18. Absence of a prothrombotic state in restenotic patients?
Brack MJ; More RS; Pringle S; Gershlick AH
Coron Artery Dis; 1994 Jun; 5(6):501-6. PubMed ID: 7952409
[TBL] [Abstract][Full Text] [Related]
19. [A study on the reserve capacity of endothelial tissue plasminogen activator in patients with acute coronary syndrome].
Yan J; Huang Z; Liu R; Li L; Han C; Yang J
Zhonghua Nei Ke Za Zhi; 1999 Dec; 38(12):817-20. PubMed ID: 11798724
[TBL] [Abstract][Full Text] [Related]
20. [Unstable angina: tissue plasminogen activator, tissue plasminogen activator inhibitors, protein C and other factors of the blood fibrinolytic system].
Zateĭshchikov DA; Averkov OV; Gratsianskiĭ NA; Dobrovol'skiĭ AB; Storozhilova AN; Ignashenkova GV; Panchenko EP
Kardiologiia; 1991 Apr; 31(4):36-8. PubMed ID: 1676768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
